Abstract
The clinical significance of HPIN and/or ASAP based on transrectal ultrasound guided biopsy (TRUS Bx) remains controversial. We reviewed the predictors for detection of and pathological features associated with prostate cancer (CaP) on repeat biopsy and the subsequent CaP detection rate for patients with prior diagnosis of HPIN, ASAP, HPIN + ASAP and no HPIN or ASAP.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
